SCHEMBL23243202

SCHEMBL23243202

COC(=O)Cc1ncc(Cl)cc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.42
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HSP90AB1 P08238 1/20 0.38
LMNA P02545 2/20 0.37
PLAU P00749 1/20 0.37
MAPT P10636 3/20 0.37
POLB P06746 1/20 0.37
NR4A1 P22736 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.35
EGFR P00533 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
PTPN1 P18031 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18335081 0.78 LMNA (0.41) HPGDALDH1A1NPC1RAB9AHSP90AB1
SCHEMBL20607916 0.77 CYP2C19 (0.42) ALDH1A1NPC1RAB9ALMNAMAPT
SCHEMBL22493741 0.76 PLAU (0.46) LMNAPLAUL3MBTL1PTPN1
SCHEMBL6076440 0.74 HPGD (0.44) HPGDALDH1A1NPC1RAB9AHSP90AB1
SCHEMBL16634805 0.72 PTPN1 (0.49) HPGDALDH1A1LMNAPLAUMAPT
SCHEMBL31006673 0.72 PTPN1 (0.49) HPGDALDH1A1LMNAPLAUMAPT
SCHEMBL18378745 0.72 PLAU (0.42) HPGDLMNAPLAUMEN1KMT2A
SCHEMBL29737883 0.72 HSP90AB1 (0.38) ALDH1A1NPC1RAB9AHSP90AB1LMNA
SCHEMBL23273501 0.72 HSP90AB1 (0.38) ALDH1A1NPC1RAB9AHSP90AB1LMNA
SCHEMBL4168644 0.72 DPP4 (0.41) ALDH1A1NPC1RAB9AHSP90AB1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4371987-B9 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS GILEAD SCIENCES INC (US) 2025-11-26 EP disclosed
EP-4371987-B1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS GILEAD SCIENCES INC (US) 2025-09-17 EP disclosed
US-12258346-B2 Substituted 6-azabenzimidazole compounds GILEAD SCIENCES, INC. (US) 2025-03-25 US disclosed
US-20240287061-A1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS GILEAD SCIENCES, INC. 2024-08-29 US disclosed
CN-113227089-B Substituted 6-azabenzimidazole compounds as HPK1 inhibitors 吉利德科学公司 2024-07-05 CN disclosed
EP-4371987-A1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS Gilead Sciences, Inc. (US) 2024-05-22 EP disclosed
US-11897878-B2 Substituted 6-azabenzimidazole compounds GILEAD SCIENCES, INC. (US) 2024-02-13 US disclosed
EP-3873903-B1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS GILEAD SCIENCES INC (US) 2024-01-24 EP disclosed
US-20220213091-A1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS GILEAD SCIENCES, INC. 2022-07-07 US disclosed
US-11203591-B2 Substituted 6-azabenzimidazole compounds GILEAD SCIENCES, INC. (US) 2021-12-21 US disclosed
EP-3873903-A1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS GILEAD SCIENCES, INC. (US) 2021-09-08 EP disclosed
CN-113227089-A Substituted 6-azabenzimidazole compounds as HPK1 inhibitors 吉利德科学公司 2021-08-06 CN disclosed
US-20210115037-A1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS GILEAD SCIENCES, INC. 2021-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287061-A1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS CDK6, HIPK1, DCK HPGD 539/4885ALDH1A1 2354/4885NPC1 1036/4885
US-12258346-B2 Substituted 6-azabenzimidazole compounds CDK6, HIPK1, DCK HPGD 539/4885ALDH1A1 2354/4885NPC1 1036/4885
US-20210115037-A1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS CDK6, HIPK1, DCK HPGD 539/4885ALDH1A1 2354/4885NPC1 1036/4885
US-11203591-B2 Substituted 6-azabenzimidazole compounds CDK6, HIPK1, DCK HPGD 539/4885ALDH1A1 2354/4885NPC1 1036/4885
US-20220213091-A1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS CDK6, HIPK1, DCK HPGD 539/4885ALDH1A1 2354/4885NPC1 1036/4885
US-11897878-B2 Substituted 6-azabenzimidazole compounds CDK6, HIPK1, DCK HPGD 539/4885ALDH1A1 2354/4885NPC1 1036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.